346 Clinical Effects of Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases

BACKGROUND: A humanized anti-interleukin-6 receptor, tocilizumab, has been approved as a biological drug for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis and Castleman's disease. Since dysregulation of IL-6 production also plays a pathologic role in other variou...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Toshio, Morishima, Atsuyoshi, Hishitani, Yoshihiro, Yoshida, Yuji, Nakabayashi, Akihiko, Ogawa, Masako, Kawai, Mari, Hirano, Toru, Hagihara, Keisuke, Shima, Yoshihito, Narazaki, Masashi, Ogata, Atsushi, Kishimoto, Tadamitsu, Kumanogoh, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Abstracts of the XXII World Allergy Congress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513059/
http://dx.doi.org/10.1097/01.WOX.0000412109.80532.b7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513059/
http://dx.doi.org/10.1097/01.WOX.0000412109.80532.b7

Ejemplares similares